GlassScriptPhysician profile
Kali Kuhlenschmidt
NPI 1558725564
$8,224.72
in general payments reported to CMS, 2019-2025
23 companies · $7,021 in 2025
The $7,021 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,204 · 2025: $7,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,353 · Education: $3,250 · Food and Beverage: $1,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,352.93 |
| Education | $3,250.00 |
| Food and Beverage | $1,621.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,873.44 | 2025 | |
| Zimmer Biomet Holdings, INC. | $2,206.86 | 2024-2025 | Advantagerib, Ribfix Titan |
| Ethicon US, LLC | $260.73 | 2024-2025 | Stratafix, Ethicon, Vistaseal |
| Polynovo North America LLC | $154.40 | 2024-2025 | Novosorb Btm |
| Takeda Pharmaceuticals U.S.A., INC. | $86.37 | 2025 | Gattex |
| Csl Behring | $79.31 | 2024-2025 | Kcentra |
| Integra Lifesciences Corporation | $76.21 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kls-Martin L.P. | $68.16 | 2024-2025 | |
| Avita Medical Americas, LLC | $58.09 | 2024 | |
| Organogenesis INC. | $41.49 | 2024-2025 | Affinity, Puraply Am |
| Depuy Synthes Sales INC. | $35.81 | 2025 | Matrixrib |
| Kerecis Limited | $35.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| W. L. Gore & Associates, INC. | $33.08 | 2024-2025 | Gore Synecor Biomaterial |
| Baxter Healthcare | $30.62 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $25.04 | 2024 | Lynparza, Keytruda |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $24.57 | 2025 | |
| Reprise Biomedical, INC. | $24.32 | 2025 | Miro3d |
| Innovation Technologies INC | $23.16 | 2025 | Irrisept |
| Solventum Corporation | $20.30 | 2025 | V.A.C.Ulta, Activ.A.C., Prevena |
| Hologic Sales and Service, LLC | $18.22 | 2024 | Coolseal Generator |
| Abbvie INC. | $17.66 | 2024 | |
| Convatec INC. | $16.12 | 2024 | |
| Boston Scientific Corporation | $15.76 | 2024 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kali Kuhlenschmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.